Therapeutics News and Research

RSS
Novel compound stops brain cell degeneration in Alzheimer's disease

Novel compound stops brain cell degeneration in Alzheimer's disease

More monitoring needed for patients taking diuretics

More monitoring needed for patients taking diuretics

Coronary artery disease patients consistently fail to take life saving drugs

Coronary artery disease patients consistently fail to take life saving drugs

Gene discovery may prevent craniofacial birth defects

Gene discovery may prevent craniofacial birth defects

Microfluidics chips for simplifying medical imaging biomarkers of disease

Microfluidics chips for simplifying medical imaging biomarkers of disease

MorphoSys signs agreement with Merck

MorphoSys signs agreement with Merck

Researchers move in on novel therapeutics to inhibit melanoma

Researchers move in on novel therapeutics to inhibit melanoma

Findings may help in development of new anti-inflammatory compounds

Findings may help in development of new anti-inflammatory compounds

Why we put weight back on

Why we put weight back on

Spear Therapeutics raise $8.5 Million to fund cancer drug development

Spear Therapeutics raise $8.5 Million to fund cancer drug development

Fullerenes can help fend off damage to normal tissue from radiation

Fullerenes can help fend off damage to normal tissue from radiation

Human umbilical cord blood cells may widen treatment window for stroke

Human umbilical cord blood cells may widen treatment window for stroke

Introgen's INGN 241 combined with Celebrex kills breast cancer cells

Introgen's INGN 241 combined with Celebrex kills breast cancer cells

Error found in standard guidelines on fetal varicella syndrome

Error found in standard guidelines on fetal varicella syndrome

Targeted drug delivery now possible using nanoparticle-apatamer conjugates

Targeted drug delivery now possible using nanoparticle-apatamer conjugates

Targeted drug delivery achieved with nanoparticle-aptamer bioconjugates

Targeted drug delivery achieved with nanoparticle-aptamer bioconjugates

EphA2 represents a promising treatment target for glioblastoma multiforme

EphA2 represents a promising treatment target for glioblastoma multiforme

Functional diffusion map to help predict brain tumor outcomes

Functional diffusion map to help predict brain tumor outcomes

Northwestern University move closer to new therapies for neurodegenerative disease

Northwestern University move closer to new therapies for neurodegenerative disease

Australian researchers determine structure of JAK2 kinase, huge implications for development of new cancer drugs

Australian researchers determine structure of JAK2 kinase, huge implications for development of new cancer drugs

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.